Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|August 15, 2008
[A case of smoking-induced chest pain improved with beta2-stimulant]Hirokazu Taniguchi, Kenta Kanbara, Shingo Imanishi, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|April 16, 2008
[A case of chest pain variant asthma with headache]Hirokazu Taniguchi, Kenta Kanbara, Shingo Imanishi, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|July 3, 2008
[Case of hepatopulmonary syndrome with no vascular dilation in chest CT]Hirokazu Taniguchi, Kenta Kanbara, Shingo Imanishi, et al.
Arerugi = [Allergy]|February 2, 2008
[Case of chest pain variant asthma]Hirokazu Taniguchi, Kenta Kanbara, Shingo Imanishi, et al.
In Vivo (Athens, Greece)|February 26, 2025
A Case of EGFR-mutant Squamous Cell Lung Cancer Treated With Necitumumab Combination TherapyMinehiko Inomata, Daisuke Furukawa, Naoki Takata, et al.
In Vivo (Athens, Greece)|December 31, 2024
Effectiveness of Chemoimmunotherapy in Small-cell Lung Cancer Patients With a Poor Performance Status or Higher Neutrophil/Lymphocyte RatioMinehiko Inomata, Naoki Takata, Zenta Seto, et al.
Tumori|December 1, 2021
Irinotecan monotherapy as third- or further-line treatment for patients with small cell lung cancerZenta Seto, Naoki Takata, Nozomu Murayama, et al.
Pathology Oncology Research : POR|September 21, 2018
Clinical Parameters for Predicting the Survival in Patients with Squamous and Non-squamous-cell NSCLC Receiving PD-1 Inhibitor TherapyMinehiko Inomata, Takahiro Hirai, Zenta Seto, et al.
Diagnostics (Basel, Switzerland)|December 1, 2020
Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI TherapyMinehiko Inomata, Kenji Azechi, Naoki Takata, et al.
Molecular and Clinical Oncology|December 12, 2025
TTF-1 expression is associated with survival in patients with non-squamous non-small cell lung cancer treated with immune checkpoint inhibitor therapyNozomu Murayama, Minehiko Inomata, Daisuke Furukawa, et al.
Pageof 4